Mednet Logo
HomeRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

What is your approach to leflunomide and statin use in RA patients?

3
2 Answers

Mednet Member
Mednet Member
Rheumatology · Stanford University

Caution is advised if leflunomide or teriflunomide must be used in patients who are currently receiving or have recently received treatment with other hepatotoxic agents, such as statins. Liver enzymes (ALT, AST, and bilirubin) should be measured prior to initiation of leflunomide/teriflunomide ther...

How do you counsel patients regarding contraception use while taking mycophenolate/mycophenolic acid?

2 Answers

Mednet Member
Mednet Member
Rheumatology · UT Southwestern Medical Center

There are some data that mycophenolate mofetil may decrease the effectiveness of oral contraceptives. In patients who are taking MMF and taking oral contraceptives as their form of contraception, an additional form of contraception is preferred. However, this is not an absolute recommendation. Mycop...

In a patient who fractures after several years of denosumab therapy, would you wait 6 months after the last denosumab injection to start an anabolic agent or could start an anabolic agent sooner?

1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

In a patient on any antiresorptive drug who fractures, we should consider an anabolic drug. A fracture does not always mean the drug has failed but we should consider changing to an anabolic since we have good evidence that anabolics have superior fracture risk reduction. Denosumab is of course mor...

What is your approach to screening for complete heart block in an asymptomatic pregnant patient with negative SSA and positive SSB antibodies?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

There are case reports of congenital heart block (CHB) due to anti-RNP antibody in anti-SSA/SSB-negative pregnant women (Izmirly et al., PMID 28709760). However, it is so rare that too many fetal heart monitoring tests would need to be done to identify these rare events. The amount of time and money...

What treatment regimen for UVA-1 have you found most helpful in treating sclerotic diseases (e.g. morphea, scleroderma)?

4 Answers

Mednet Member
Mednet Member
Dermatology · Feinberg School of Medicine

In our department, we have had success with the following treatment regimen with UVA-1 for sclerotic diseases. The following protocol is for full-body UVA-1 (appropriate for generalized morphea, systemic sclerosis). Low dose is considered 10-30 J/cm2, medium is 30-40 J/cm2 and high is 50-60 J/cm2. W...

Do you typically get muscle MRI in patients with symptoms of myopathy?

2
1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Not routinely, but there are some scenarios where MRI is useful. Selection of muscle to biopsy in a chronic progressive myopathy. In the past, we used to select muscles based on the degree of weakness on the MRC scale and the EMG findings. One would avoid muscles with MRC strength of 3/5 or less or...

How do you counsel patients about the malignancy risk associated with azathioprine?

1 Answers

Mednet Member
Mednet Member
Rheumatology · UTMB Health

Malignancy with the use of AZA (Imuran) was documented many decades ago in a renal transplant population, not in rheumatoid patients. Are they equivalent? Overall I consider Imuran a pretty safe DMARD. In fact, it can be used in pregnant patients with lupus, with mothers and babies doing just fine.

Is there any role of sympathectomy in Raynaud’s disease?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Sympathectomy was once considered to be the treatment of last resort for severe, refractory Raynaud's. Though severe Raynaud's remains a challenging disorder to manage, nowadays, sympathectomy rarely if ever enters the therapeutic discussion. Though most patients with Raynaud's phenomenon observed a...

What is your approach to therapy for pulmonary sarcoidosis resistant to methotrexate?

1
1 Answers

Mednet Member
Mednet Member
Pulmonology · Medical University of South Carolina

The first question I ask myself in any situation dealing with "refractory" sarcoidosis is "Am I sure active inflammation from sarcoidosis is the cause of their symptoms?". Oftentimes, I will see patients referred for refractory disease who end up having other causes of their symptoms. If I am confid...

How do you approach evaluation of hypocomplementemia in a patient with arthralgias and a history of Hodgkin's lymphoma treated in the past?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Cincinnati

There are both acquired disorders - more common - of the complement system and inherited disorders - less common - of the complement system. Although rheumatologists commonly deal with autoimmune/acquired disorders of the immune system, they should be aware that certain inherited deficiencies of the...